Neointima-inducing inflow cannula with titanium mesh for left ventricular assist device

Journal of Artificial Organs

Volumn 14, Issue 4, 2011, Pages 269-275

  Yamada, Yukiko ^a   Nishinaka, Tomohiro ^a   Mizuno, Toshihide ^b   Taenaka, Yoshiyuki ^b   Tatsumi, Eisuke ^b   Yamazaki, Kenji ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Inflow cannula; Left ventricular assist device; Neointima; Thromboembolism

Indexed keywords

BILIRUBIN; CREATININE; HEMOGLOBIN; NITROGEN; UREA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; BLOOD PUMP; CALF (MAMMAL); CANNULA; DEVICE SAFETY; ENDOCARDIUM; ENDOTHELIUM CELL; FEASIBILITY STUDY; FIBROBLAST; GRINDING; HEART HEMODYNAMICS; HISTOLOGY; IMMUNOHISTOCHEMISTRY; INFLOW CANNULA; LEFT VENTRICULAR ASSIST DEVICE; LUNG BLOOD FLOW; NEOINTIMA; NONHUMAN; PRIORITY JOURNAL; SURGICAL EQUIPMENT; THROMBOEMBOLISM; UREA NITROGEN BLOOD LEVEL;

ANIMALS; CATHETERS; CATTLE; HEART-ASSIST DEVICES; IMMUNOHISTOCHEMISTRY; NEOINTIMA; THROMBOSIS; TISSUE SCAFFOLDS; TITANIUM;

EID: 84855287666     PISSN: 14347229     EISSN: 16190904     Source Type: Journal    
DOI: 10.1007/s10047-011-0586-4     Document Type: Article

References (19)

1. Navia JL, McCarthy PM, Hoercher KJ, Smedira NG, Banbury MK, Blackstone EH. Do left ventricular assist device bridge-totransplantation outcomes predict the results of permanent LVAD implantation? Ann Thorac Surg. 2002;74:2051-63. (Pubitemid 35440878)
2. Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, Long JW, Ascheim DD, Tierney AR, Levitan RG, Watson JT, Meier P. Long-term use of a left ventricularassist device for end-stage heart failure. NEJM. 2001;345: 1435-43.
3. Frazier OH, Baldwin RT, Eskin SG, Duncan JM. Immunochemical identification of human endothelial cells on the lining of a ventricular assist device. Tex Heart Inst J. 1993;20:78-82. (Pubitemid 23176322)
4. Rose EA, Levin HR, Oz MC, Frazier OH, Macmanus QW, Burton NA, Lefrak EA. Artificial circulatory support with textured interior surface. A counterintuitive approach to minimizing thromboembolism. Circulation. 1994;90:II87-91. (Pubitemid 24349251)
5. Frazier OH, Gemmato CG, Myers TJ, Gregoric ID, Radovancevic B, Loyalka P, Kar BK. Initial clinical experience with the HeartMate II axial-flow left ventricular assist device. Tex Heart Inst J. 2007;34:275-81. (Pubitemid 350057567)
6. Schmid C, Jurmann M, Birnbaum D, Colombo T, Falk V, Feltrin G, Garatti A, Genoni M, Gerosa G, Göttel P, Gummert J, Halfmann R, Hammel D, Hennig E, Kaufmann F, Lanfranconi M, Meyns B, Mohr F, Müller J, Nikolov D, Rucinskas K, Scheld HH, Schmid FX, Schneider M, Sirvydis V, Tandler R, Vitali E, Vlasselaers D, Weyand M, Wilhelm M, Hetzer R. Influence of inflow cannula length in axial-flow pumps on neurologic adverse event rate: results from a multi-center analysis. J Heart Lung Transplant. 2008;27:253-60. (Pubitemid 351403653)
7. Schmid C, Weyand M, Nabavi DG, Hammel D, Deng MC, Ringelstein EB, Scheld HH. Cerebral and systemic embolization during left ventricular support with the Novacor N100 device. Ann Thorac Surg. 1998;65:1703-10.
8. Mussivand T, Hetzer R, Vitali E, Meyns B, Noirhomme P, Koerfer R, El-Banayosy A, Wolner E, Wieselthaler G, Reichart B, Uberfuhr P, Halfmann R, Portner P. Clinical results with an ePTFE inflow conduit for mechanical circulatory support. J Heart Lung Transplant. 2004;23:1366-70. (Pubitemid 40018158)
9. Frazier OH, Forrester MD, Gemmato C, Gregoric ID. Urgent pump exchange for stroke resulting from a distorted HeartMate XVE inflow conduit. J Heart Lung Transplant. 2007;26:646-8. (Pubitemid 46818049)
10. Kurihara C, Ono M, Nishimura T, Saito A, Taketani T, Hisagi M, Nawata K, Kinoshita O, Morota T, Motomura N, Kyo S. Use of DuraHeart support for more than 1 year as the first successful bridge to heart transplantation in Japan. J Artif Organs. 2010;14:67-9.
11. Yamazaki K, Litwak P, Tagusari O, Mori T, Kono K, Kameneva M, Watach M, Gordon L, Miyagishima M, Tomioka J, Umezu M, Outa E, Antaki JF, Kormos RL, Koyanagi H, Griffith B. An implantable centrifugal blood pump with a recirculating purge system (Cool-seal system). Artif Organs. 1998;22:466-74. (Pubitemid 28353964)
12. Yamazaki K, Saito S, Kihara S, Tagusari O, Kurosawa H. Completely pulsatile high flow circulatory support with a constant speed centrifugal blood pump: mechanisms and early clinical observations. Gen Thorac Cardiovasc Surg. 2007;55:158-62.
13. Dasse KA, Chipman SD, Sheaman CN, Levine AH, Frazier OH. Clinical experience with textured blood contacting surfaces in ventricular assist devices. Trans Am Soc Artif Intern Organs. 1987;33:418-25.
14. Gordon PB, Sussman II, Hatcher VB. Long-term culture of human endothelial cells. In vitro Cell Dev Biol. 1983;19:661-71. (Pubitemid 15212476)
15. Hoshi H, WcKeehan W. Isolation, growth requirements, cloning, prostacyclin production and life-span of human adult endothelial cells in low serum culture medium. In vitro Cell Dev Biol. 1986;22(1):51-6. (Pubitemid 16167960)
16. Berger K, Sauvage LR, Rao AM, Wood SJ. Healing of arterial prostheses in man: its incompleteness. Ann Surg. 1972;175: 118-27.
17. Sigler M, Jux C, Ewert P. Histopathological workup of an amplatzer atrial septal defect occluder after surgical removal. Pediatr Cardiol. 2006;27:775-6. (Pubitemid 44915421)
18. Sigler M, Jux C. Biocompatibility of septal defect closure device. Heart. 2007;93:444-9. (Pubitemid 46631507)
19. Foth R, Quentin T, Michel-Behnke I, Vogt M, Kriebel T, Kreischer A, Ruschewski W, Paul T, Sigler T. Immunohistochemical characterization of neotissues and tissue reactions to septal defect occlusion devices. Circ Cardiovasc Intervent. 2009;2:90-6.